Transfer of Non-Core Products to Focus on Neonatal

AI SummaryClose X

Inspiration Healthcare Group plc has entered into a framework agreement with Micrel Medical Devices SA to transfer the distribution of Micrel's infusion products in the UK, effective January 31, 2027. These products generated £9.7 million in revenue with a 25% contribution margin for the year ended January 31, 2026. The transition will involve employee transfers under TUPE from July 1, 2026, and a compensation payment from Micrel for an orderly business transition. The company expects these savings and the payment to reduce net debt by approximately 20% in FY27, with no impact on current financial year revenue and gross profit estimates. This strategic move allows Inspiration Healthcare to focus on its core neonatal business.

Disclaimer*

UK 100

Latest directors dealings